There is no quick fix
![](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article3001045.ece/ALTERNATES/schema-16_9/Kirsten%2520Drejer.jpg)
She is a product of Novo Nordisk and is currently working around the clock to discover new drugs that will improve treatment for cancer patients. Twelve and a half years ago Kirsten Drejer parted ways with the Danish drug giant, where she had been employed for 18 years, to begin on her own.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.